C McGarigle
Overview
Explore the profile of C McGarigle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
199
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Porter D, Connors J, Van Deerlin V, Duffy K, McGarigle C, Saidman S, et al.
J Clin Oncol
. 1999 Nov;
17(4):1234.
PMID: 10561184
Purpose: Histocompatible allogeneic donor leukocyte infusions (DLIs) were administered as primary cancer therapy in a phase I trial to determine (1) whether mixed chimerism could be detected without a prior...
2.
Chang G, McGarigle C, Spitzer T, McAfee S, Harris F, Piercy K, et al.
Psychosom Med
. 1998 Apr;
60(2):163-7.
PMID: 9560864
Objective: The purpose of this investigation is to test whether related bone marrow donors experience more distress from marrow donation than volunteer unrelated donors. Method: Participants in the study were...
3.
Chan C, Molrine D, Antin J, Wheeler C, Guinan E, Weinstein H, et al.
Bone Marrow Transplant
. 1997 Jul;
20(1):33-8.
PMID: 9232253
Accelerated granulocyte and platelet recovery following peripheral blood stem cell transplantation (PBSCT) are well documented. We hypothesize that functional immunity may also be enhanced in PBSCT and performed a phase...
4.
Chang G, Antin J, Orav E, Randall U, McGarigle C, Behr H
Am J Drug Alcohol Abuse
. 1997 May;
23(2):301-8.
PMID: 9143640
The purpose of this retrospective study is to test the hypothesis that lifetime substance abuse has an adverse impact on survival after bone marrow transplant (BMT). This study included 17...
5.
Porter D, Roth M, Lee S, McGarigle C, Ferrara J, Antin J
Bone Marrow Transplant
. 1996 Nov;
18(5):975-80.
PMID: 8932854
Relapse remains a significant problem after allogeneic bone marrow transplantation (BMT). For patients with relapsed chronic myelogenous leukemia (CML), infusions of donor mononuclear cells (MNC) provide a potent graft-versus-leukemia (GVL)...
6.
Molrine D, Guinan E, Antin J, Wheeler C, Parsons S, Weinstein H, et al.
Bone Marrow Transplant
. 1996 Jun;
17(6):1149-55.
PMID: 8807128
Immune reconstitution following autologous bone marrow transplantation (ABMT) is characterized by defects in B cell and T cell function and loss of specific antibody. In the late post-transplant period, patients...
7.
Molrine D, Guinan E, Antin J, Parsons S, Weinstein H, Wheeler C, et al.
Blood
. 1996 Apr;
87(7):3012-8.
PMID: 8639924
Bone marrow transplant patients are at increased risk for infections with polysaccharide encapsulated organisms and respond poorly to polysaccharide vaccines. We evaluated the effect of donor immunization with Haemophilus influenzae...
8.
Andrykowski M, Greiner C, Altmaier E, Burish T, Antin J, Gingrich R, et al.
Br J Cancer
. 1995 Jun;
71(6):1322-9.
PMID: 7779732
Questionnaires assessing a range of quality of life (QOL) outcomes were completed by 200 adult bone marrow transplant (BMT) recipients from five BMT treatment centres. Respondents had undergone allogeneic (46%)...
9.
Andrykowski M, Brady M, Greiner C, Altmaier E, Burish T, Antin J, et al.
Bone Marrow Transplant
. 1995 Apr;
15(4):573-81.
PMID: 7655384
The psychosocial impact of bone marrow transplantation (BMT) was investigated in 172 disease-free adult BMT survivors drawn from five different BMT treatment centers. Respondents were a mean of 43.5 months...
10.
Pai S, Fruman D, Leong T, Neuberg D, Rosano T, McGarigle C, et al.
Blood
. 1994 Dec;
84(11):3974-9.
PMID: 7949153
In vitro studies have demonstrated that cyclosporine A (CsA) acts by inhibiting the phosphatase activity of calcineurin, an important mediator of T-cell activation. The relationship of CsA administration in vivo,...